These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28462857)

  • 1. Disparities in the Receipt of Local Treatment of Node-positive Prostate Cancer.
    Muralidhar V; Mahal BA; Rose BS; Chen YW; Nezolosky MD; Efstathiou JA; Beard CJ; Martin NE; Orio PF; Trinh QD; Choueiri TK; Sweeney CJ; Nguyen PL
    Clin Genitourin Cancer; 2017 Oct; 15(5):563-569.e3. PubMed ID: 28462857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Income inequality and treatment of African American men with high-risk prostate cancer.
    Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
    Bagley AF; Anscher MS; Choi S; Frank SJ; Hoffman KE; Kuban DA; McGuire SE; Nguyen QN; Chapin B; Aparicio A; Pezzi TA; Smith GL; Smith BD; Hess K; Tang C
    JAMA Netw Open; 2020 Mar; 3(3):e201255. PubMed ID: 32191331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance.
    Mahal AR; Mahal BA; Nguyen PL; Yu JB
    Cancer; 2018 Feb; 124(4):752-759. PubMed ID: 29084350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer.
    Jegadeesh N; Liu Y; Zhang C; Zhong J; Cassidy RJ; Gillespie T; Kucuk O; Rossi P; Master VA; Alemozaffar M; Jani AB
    Cancer; 2017 Feb; 123(3):512-520. PubMed ID: 27859018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
    Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
    J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study.
    Rusthoven CG; Carlson JA; Waxweiler TV; Raben D; Dewitt PE; Crawford ED; Maroni PD; Kavanagh BD
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1064-73. PubMed ID: 24661660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009.
    Yeboa DN; Xu X; Jones BA; Soulos P; Gross C; Yu JB
    Am J Clin Oncol; 2016 Dec; 39(6):568-574. PubMed ID: 24879475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Outcomes in Men Undergoing Radical Prostatectomy After Primary Radiation Treatment for Adenocarcinoma of the Prostate.
    Pokala N; Huynh DL; Henderson AA; Johans C
    Clin Genitourin Cancer; 2016 Jun; 14(3):218-25. PubMed ID: 26774347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer.
    Vetterlein MW; Löppenberg B; Karabon P; Dalela D; Jindal T; Sood A; Chun FK; Trinh QD; Menon M; Abdollah F
    Cancer; 2017 Sep; 123(17):3241-3252. PubMed ID: 28472547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National trends in the recommendation of radiotherapy after prostatectomy for prostate cancer before and after the reporting of a survival benefit in March 2009.
    Mahal BA; Hoffman KE; Efstathiou JA; Nguyen PL
    Clin Genitourin Cancer; 2015 Jun; 13(3):e167-72. PubMed ID: 25554010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
    Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
    J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic Adenocarcinoma.
    Sanford NN; Aguilera TA; Folkert MR; Ahn C; Mahal BA; Zeh H; Beg MS; Mansour J; Sher DJ
    J Natl Compr Canc Netw; 2019 Nov; 17(11):1292-1300. PubMed ID: 31693987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
    Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
    Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant increase in prostatectomy and decrease in radiation for clinical T3 prostate cancer from 1998 to 2012.
    Nezolosky MD; Dinh KT; Muralidhar V; Mahal BA; Chen YW; Beard CJ; Choueiri TK; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    Urol Oncol; 2016 Feb; 34(2):57.e15-22. PubMed ID: 26476663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Therapy Improves Overall Survival in Patients With Newly Diagnosed Metastatic Prostate Cancer.
    Parikh RR; Byun J; Goyal S; Kim IY
    Prostate; 2017 May; 77(6):559-572. PubMed ID: 28093791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in cancer treatment among patients infected with the human immunodeficiency virus.
    Suneja G; Lin CC; Simard EP; Han X; Engels EA; Jemal A
    Cancer; 2016 Aug; 122(15):2399-407. PubMed ID: 27187086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in time from prostate cancer diagnosis to treatment initiation: a population-based study.
    Stokes WA; Hendrix LH; Royce TJ; Allen IM; Godley PA; Wang AZ; Chen RC
    Cancer; 2013 Jul; 119(13):2486-93. PubMed ID: 23716470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of initial local therapy on survival in men later receiving chemotherapy for prostate cancer: a population-based, propensity-weighted multivariable analysis.
    Zabell JR; Adejoro O; Jarosek SL; Elliott SP; Konety BR
    World J Urol; 2016 Oct; 34(10):1397-403. PubMed ID: 26914817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.